Nadolol
Back to searchMolecule Structure
Scientific Name
Nadolol
Description of the Drug
Nadolol is a non-selective beta-adrenergic antagonist used for the management of arrhythmias, angina pectoris, and hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01203
http://www.drugbank.ca/drugs/DB01203
Brand Name(s)
Corgard, Nadolol, Solgol
Company Owner(s)
Amneal Pharmaceuticals Co Gmbh, Impax Laboratories Inc, King Pharmaceuticals Llc, Sandoz Inc, Uswm Llc, Invagen Pharmaceuticals Inc, Novast Laboratories Ltd, Vgyaan Pharmaceuticals Llc, Aurobindo Pharma Ltd, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-1 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL213 |
| Beta-2 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4177 | |
| PharmGKB | PA450573 | |
| Human Metabolome Database | HMDB0015334 | |
| DrugBank | DB01203 | |
| PubChem | 39147 | |
| LINCS | LSM-1879 | |
| BindingDB | 25766 | |
| EPA CompTox Dashboard | DTXSID3023342 | |
| ChemicalBook | CB2494641 | |
| Guide to Pharmacology | 554 | |
| rxnorm | CORGARD | NADOLOL |
| PubChem: Drugs of the Future | 12013396 |
